Correlation Between Advanced Proteome and Geron

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Advanced Proteome and Geron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Advanced Proteome and Geron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Advanced Proteome Therapeutics and Geron, you can compare the effects of market volatilities on Advanced Proteome and Geron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Advanced Proteome with a short position of Geron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Advanced Proteome and Geron.

Diversification Opportunities for Advanced Proteome and Geron

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Advanced and Geron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Advanced Proteome Therapeutics and Geron in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Geron and Advanced Proteome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Advanced Proteome Therapeutics are associated (or correlated) with Geron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Geron has no effect on the direction of Advanced Proteome i.e., Advanced Proteome and Geron go up and down completely randomly.

Pair Corralation between Advanced Proteome and Geron

Assuming the 90 days horizon Advanced Proteome Therapeutics is expected to under-perform the Geron. But the pink sheet apears to be less risky and, when comparing its historical volatility, Advanced Proteome Therapeutics is 1.11 times less risky than Geron. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Geron is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  301.00  in Geron on September 1, 2024 and sell it today you would earn a total of  111.00  from holding Geron or generate 36.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.78%
ValuesDaily Returns

Advanced Proteome Therapeutics  vs.  Geron

 Performance 
       Timeline  
Advanced Proteome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Geron 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Geron is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Advanced Proteome and Geron Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Advanced Proteome and Geron

The main advantage of trading using opposite Advanced Proteome and Geron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Advanced Proteome position performs unexpectedly, Geron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will offset losses from the drop in Geron's long position.
The idea behind Advanced Proteome Therapeutics and Geron pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance